Health Trials

Prevention of Emergence Agitation in Rhinoplasty With Subanesthetic Propofol and Single-Dose Dexmedetomidine: A Prospective Double-Blind Clinical Study

ConditionEmergence Agitation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorYuzuncu Yil University

About this trial

To compare of prevention of emergence agitation in rhinoplasty with subanesthetic propofol and single dose dexmedetomidine

Eligibility criteria

Qualifiers

Patients scheduled for rhinoplasty

Between 18-65 years

ASA I-II group

Disqualifiers

Those who are outside the age range of 18-65

Those who are ASA III and above

Those with renal,hepatic, cardiac and respiratory diseases

Those with a known allergy to the medication to be used

Trial design

Treatments tested in this trial

  • Dexmedetomidine
  • Propofol

Treatment groups

80 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Yuzuncu Yil University

Lead sponsor

Source ClinicalTrials.gov